| Save | Compare | ID | Name | Sequence | Length | Level PepDiana tier derived from the internal quality score plus activity and literature coverage; it is not an external database rating. | Mass | Structure | Quality PepDiana 0–100 composite of sequence, source, activity, literature, and cross-database evidence completeness. | DBs | Primary evidence |
|---|---|---|---|---|---|---|---|---|---|---|---|
| PEPDIA-INT-070410 | Unnamed peptide | VHLPP | 5 | GoldPepDiana tier derived from the internal quality score plus activity and literature coverage; it is not an external database rating. | 561.7 Da | Linear | 85 |
| 5 |
| - |
| PEPDIA-INT-002975 | (KW)3 | KWKWKW | 6 | GoldPepDiana tier derived from the internal quality score plus activity and literature coverage; it is not an external database rating. | 961.2 Da | Linear | 85PepDiana 0–100 composite of sequence, source, activity, literature, and cross-database evidence completeness. | 6 | - |
| PEPDIA-INT-034927 | Unnamed peptide | HCKFWA | 6 | GoldPepDiana tier derived from the internal quality score plus activity and literature coverage; it is not an external database rating. | 790.9 Da | Linear | 85PepDiana 0–100 composite of sequence, source, activity, literature, and cross-database evidence completeness. | 4 | - |
| PEPDIA-INT-039569 | Sequence 2 from Patent US 20030195150 | TTMPLW | 6 | GoldPepDiana tier derived from the internal quality score plus activity and literature coverage; it is not an external database rating. | 747.9 Da | Linear | 85PepDiana 0–100 composite of sequence, source, activity, literature, and cross-database evidence completeness. | 6 | - |
| PEPDIA-INT-040166 | PAF26 | RKKWFW | 6 | GoldPepDiana tier derived from the internal quality score plus activity and literature coverage; it is not an external database rating. | 950.2 Da | Linear | 85PepDiana 0–100 composite of sequence, source, activity, literature, and cross-database evidence completeness. | 7 | - |
| PEPDIA-INT-042391 | Unnamed peptide | HCKFWW | 6 | GoldPepDiana tier derived from the internal quality score plus activity and literature coverage; it is not an external database rating. | 906.1 Da | Linear | 85PepDiana 0–100 composite of sequence, source, activity, literature, and cross-database evidence completeness. | 4 | - |
| PEPDIA-INT-056024 | PolyP 4 | VHLPPP | 6 | GoldPepDiana tier derived from the internal quality score plus activity and literature coverage; it is not an external database rating. | 658.8 Da | Linear | 85PepDiana 0–100 composite of sequence, source, activity, literature, and cross-database evidence completeness. | 5 | - |
| PEPDIA-INT-065511 | Unnamed peptide | HCKFWI | 6 | GoldPepDiana tier derived from the internal quality score plus activity and literature coverage; it is not an external database rating. | 833.0 Da | Linear | 85PepDiana 0–100 composite of sequence, source, activity, literature, and cross-database evidence completeness. | 4 | - |
| PEPDIA-INT-076346 | Unnamed peptide | HCKFWF | 6 | GoldPepDiana tier derived from the internal quality score plus activity and literature coverage; it is not an external database rating. | 867.0 Da | Linear | 85PepDiana 0–100 composite of sequence, source, activity, literature, and cross-database evidence completeness. | 4 | - |
| PEPDIA-INT-076514 | (RW)3 | RWRWRW | 6 | GoldPepDiana tier derived from the internal quality score plus activity and literature coverage; it is not an external database rating. | 1045.2 Da | Linear | 85PepDiana 0–100 composite of sequence, source, activity, literature, and cross-database evidence completeness. | 8 | 48 records1 papers29 negative |
| PEPDIA-INT-058927 | ACE inhibitor from soybean | PGTAVFK | 7 | GoldPepDiana tier derived from the internal quality score plus activity and literature coverage; it is not an external database rating. | 718.9 Da | Linear | 85PepDiana 0–100 composite of sequence, source, activity, literature, and cross-database evidence completeness. | 5 | - |
| PEPDIA-INT-005373 | Caseicin B | VLNENLLR | 8 | GoldPepDiana tier derived from the internal quality score plus activity and literature coverage; it is not an external database rating. | 970.1 Da | - | 85PepDiana 0–100 composite of sequence, source, activity, literature, and cross-database evidence completeness. | 4 | - |
| PEPDIA-INT-028075 | Antimicrobial peptide (LLKK)2 | LLKKLLKK | 8 | GoldPepDiana tier derived from the internal quality score plus activity and literature coverage; it is not an external database rating. | 983.4 Da | Linear | 85PepDiana 0–100 composite of sequence, source, activity, literature, and cross-database evidence completeness. | 4 | - |
| PEPDIA-INT-034101 | RW4 | RWRWRWRW | 8 | GoldPepDiana tier derived from the internal quality score plus activity and literature coverage; it is not an external database rating. | 1387.6 Da | Linear | 85PepDiana 0–100 composite of sequence, source, activity, literature, and cross-database evidence completeness. | 9 | - |
| PEPDIA-INT-040796 | Unnamed peptide | IYWNVSGW | 8 | GoldPepDiana tier derived from the internal quality score plus activity and literature coverage; it is not an external database rating. | 1024.1 Da | Linear | 85PepDiana 0–100 composite of sequence, source, activity, literature, and cross-database evidence completeness. | 4 | - |
| PEPDIA-INT-044040 | (KW)4 | KWKWKWKW | 8 | GoldPepDiana tier derived from the internal quality score plus activity and literature coverage; it is not an external database rating. | 1275.6 Da | Linear | 85PepDiana 0–100 composite of sequence, source, activity, literature, and cross-database evidence completeness. | 5 | - |
| PEPDIA-INT-065994 | Temporin-SHf | FFFLSRIF | 8 | GoldPepDiana tier derived from the internal quality score plus activity and literature coverage; it is not an external database rating. | 1076.3 Da | Linear | 85PepDiana 0–100 composite of sequence, source, activity, literature, and cross-database evidence completeness. | 6 | 25 records1 papers2 complex |
| PEPDIA-INT-004265 | Defensin-derived L-Peptide C | ALYLAIRRR | 9 | GoldPepDiana tier derived from the internal quality score plus activity and literature coverage; it is not an external database rating. | 1131.4 Da | Linear | 85PepDiana 0–100 composite of sequence, source, activity, literature, and cross-database evidence completeness. | 5 | - |
| PEPDIA-INT-010628 | DnsLK9(2.0) | KLKLKLKLK | 9 | GoldPepDiana tier derived from the internal quality score plus activity and literature coverage; it is not an external database rating. | 1111.5 Da | Linear | 85PepDiana 0–100 composite of sequence, source, activity, literature, and cross-database evidence completeness. | 3 | - |
| PEPDIA-INT-018107 | Caseicin A | IKHQGLPQE | 9 | GoldPepDiana tier derived from the internal quality score plus activity and literature coverage; it is not an external database rating. | 1049.2 Da | - | 85PepDiana 0–100 composite of sequence, source, activity, literature, and cross-database evidence completeness. | 3 | - |
